These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Dietary treatment of hyperlipoproteinemia]. Chanu B Soins; 1987 Jul; (502):15-20. PubMed ID: 3672152 [No Abstract] [Full Text] [Related]
5. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV]. Romics L; Karádi I; Simonyi E Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011 [No Abstract] [Full Text] [Related]
6. Primary type I hyperlipoproteinemia. Agarwal BR; Rajyadhyaksha S; Merchant RH; Parekh SR; Paranjpe AS Indian Pediatr; 1985 Sep; 22(9):705-7. PubMed ID: 3833791 [No Abstract] [Full Text] [Related]
7. Plasma lipoprotein composition in different types of hyperlipoproteinemias in Northern India. Gandhi BM; George PK J Assoc Physicians India; 1982 Nov; 29(11):913-9. PubMed ID: 7130109 [No Abstract] [Full Text] [Related]
8. [Classification of hyperlipoproteinemia in the light of advances in pathogenetic studies]. Pometta D; James RW; Leowski J; Packard CJ; Shepherd J Pol Tyg Lek; 1985 Dec; 40(50):1389-94. PubMed ID: 3831987 [No Abstract] [Full Text] [Related]
9. Pregnancy-induced hyperlipoproteinemia: review of the literature. Basaran A Reprod Sci; 2009 May; 16(5):431-7. PubMed ID: 19233944 [TBL] [Abstract][Full Text] [Related]
10. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424 [TBL] [Abstract][Full Text] [Related]
11. [Classification of dyslipoproteinemias of genetic origin]. Brousseau T; Fruchart JC Ann Med Interne (Paris); 1993; 144(4):275-81. PubMed ID: 8368721 [No Abstract] [Full Text] [Related]
14. [Epidemiology of nutritional disorders. III. Data on the epidemiology of hyperlipoproteinemia]. Creţeanu G; Ivan A; Teodorovici G Rev Med Chir Soc Med Nat Iasi; 1981; 85(3):407-11. PubMed ID: 7038808 [No Abstract] [Full Text] [Related]
15. [Classification of hyperlipoproteinemias and interpretation of laboratory parameters]. Herrmann W; Lackner KJ; Schmitz G Wien Med Wochenschr; 1994; 144(12-13):292-9. PubMed ID: 8650932 [TBL] [Abstract][Full Text] [Related]
18. [Single-blind study of the efficacy of pirozadil versus alufibrate in the treatment of primary hyperlipoproteinemias]. Honorato Pérez J; Azanza Perea JR Rev Med Univ Navarra; 1982 Mar; 26(1):51-4. PubMed ID: 7111953 [TBL] [Abstract][Full Text] [Related]